Đang chuẩn bị liên kết để tải về tài liệu:
Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Brain metastases often occur in cancer evolution. They are not only responsible for death but also for disorders affecting the quality of life and the cognitive functions. | Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal STEREO-HBM a two-step phase 2 trial

TÀI LIỆU LIÊN QUAN

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: A phase III randomised multicentre trial

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): Study protocol for a randomized phase III trial

Hypofractionated stereotactic radiotherapy of limited brain metastases: A single-centre individualized treatment approach

Distress, anxiety and depression in patients with brain metastases before and after radiotherapy

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial

Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastases

Preoperative stereotactic radiosurgery for brain metastases: The STEP study protocol for a multicentre, prospective, phase-II trial

Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: Study protocol for a multicenter open-label randomized phase II trial

Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients

Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases